tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
HUTCHMED (HCM)
NASDAQ:HCM
US Market
HCM
HUTCHMED
RESEARCH TOOLSreports

HUTCHMED (HCM) Stock News & Sentiment

Compare
210 Followers
Hutchmed’s HMPL-506 Study: A Potential Game-Changer in Hematological Malignancies
Premium
Company Announcements
Hutchmed’s HMPL-506 Study: A Potential Game-Changer in Hematological Malignancies
3M ago
HCM
Hutchmed’s Promising Study in Metastatic Pancreatic Cancer: A Potential Game Changer
Premium
Company Announcements
Hutchmed’s Promising Study in Metastatic Pancreatic Cancer: A Potential Game Changer
3M ago
HCM
Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
Premium
Company Announcements
Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
3M ago
HCM
Hutchmed’s Phase I Study on HMPL-306: A Promising Step in Glioma Treatment
Premium
Company Announcements
Hutchmed’s Phase I Study on HMPL-306: A Promising Step in Glioma Treatment
3M ago
HCM
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment
Premium
Company Announcements
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment
3M ago
HCM
Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
Premium
Company Announcements
Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
5M ago
HCM
HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges
Premium
Ratings
HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges
5M ago
HCM
More HCM News >

HCM News on the Web

Weekly Buzz: ScinoPharm Gets FDA Nod; GNLX's Olvi-Vec Shows Promise; GLUE's MRT-8102 Advances
rttnews
Neutral
Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know
Zacks
Bullish
HUTCHMED's ESLIM-02 Trial Of Sovleplenib In Warm Autoimmune Hemolytic Anemia Meets Key Goal
rttnews
Neutral
HUTCHMED Begins Phase 3 Part Of Phase 2/3 Surufatinib-Camrelizumab Combo Study In Pancreatic Cancer
rttnews
Neutral
HUTCHMED's Fanregratinib Receives Priority Review In China For FGFR2 Cholangiocarcinoma- Update
rttnews
Neutral
Hutchmed's NDA For Fanregratinib In Intrahepatic Cholangiocarcinoma Accepted In China
rttnews
Neutral
CICC Remains a Buy on HUTCHMED (China) (HCM)
TipRanks News
Neutral
Why HUTCHMED (China) Limited’s (HCM) Stock Is Up 9.77%
AAII
Neutral

News Score - Last 7 Days

Neutral
HCM
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HCM’s Media Buzz Sentiment?
4 articles about HCM were published this week. In an average week, 1.5 articles are published.
    What is HCM’s weekly average amount of articles?
    In an average week, 1.5 articles about HCM are published.
      What is HCM’s News Sentiment?
      100% of articles about HCM were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        RVMDRevolution Medicines
        REGNRegeneron
        KRYSKrystal Biotech
        GNPXGenprex
        RIGLRigel
        Showing the stocks with the most bullish news sentiment over the past week